Pascale Charbonnel holds a PhD in Molecular Microbiology Sciences from the Université de Paris XI – Orsay, France. She has been working in the Health Industry since 2004 both in animal and human health. From 2007 to 2012 she led animal vaccines development projects in R&D at Boehringer Ingelheim Animal Health France (Merial-legacy). She transitioned into Key Accounts and Alliances Management with Government and Public-Private vaccine manufacturers in Asia/Middle-East (South Korea, Vietnam, Thailand, Egypt), a post she held for six years.

Being truly passionate about people and scientific innovation, she naturally evolved as a skilled business developer joining innovative equipment company, Ovizio, to develop business expansion towards new market applications (cell therapy and vaccine products) and added new territories in East Asia. She recently joined the SCTbio family to support business development activities.